GlobeNewswire 11/06/2024 Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPi...
GlobeNewswire 01/06/2024 Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin)...
GlobeNewswire 16/05/2024 Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional...
GlobeNewswire 29/04/2024 Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supportin...
GlobeNewswire 19/04/2024 Life Science Cares Launches in Switzerland
GlobeNewswire 17/04/2024 Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
GlobeNewswire 26/03/2024 Molecular Partners Publishes Invitation to Annual General Meeting 2024
GlobeNewswire 14/03/2024 Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
GlobeNewswire 01/03/2024 Molecular Partners Announces Dismissal of Class Action Lawsuit
GlobeNewswire 01/03/2024 Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and ...
GlobeNewswire 07/01/2024 Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 05/01/2024 Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies
GlobeNewswire 14/12/2023 Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Co...
GlobeNewswire 10/12/2023 Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/...
GlobeNewswire 14/11/2023 Molecular Partners to Present on DARPin Oncology Innovations at Protein & Antibody Engineering Summi...
GlobeNewswire 03/11/2023 Molecular Partners Presents Updated Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) ...
GlobeNewswire 02/11/2023 Molecular Partners to Present Initial Data from Ongoing Phase 1/2a Trial of MP0533 for Patients with...
GlobeNewswire 01/11/2023 Molecular Partners to Participate in the TD Cowen 7th Annual Fall Oncology Innovation Summit
GlobeNewswire 26/10/2023 Molecular Partners Interim Management Statement Q3 2023: Continued Validation Seen Across the DARPin...
GlobeNewswire 13/09/2023 Molecular Partners Presents New Data on its Radio DARPin Therapy (RDT) Platform at the EANM 2023 Ann...
GlobeNewswire 24/08/2023 Molecular Partners Reports H1 2023 Corporate Highlights and Financials
GlobeNewswire 24/03/2022 Molecular Partners Announces Publication of Preclinical Data from CD40 Therapeutic Candidate MP0317 ...
GlobeNewswire 17/03/2022 Molecular Partners Publishes Invitation to Annual General Meeting 2022
GlobeNewswire 15/03/2022 Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
GlobeNewswire 25/02/2022 Molecular Partners to Present at Upcoming Healthcare Investor Conferences